Diseases [C] » Cardiovascular Diseases [C14] » Cardiovascular Abnormalities » Heart Defects, Congenital » Tetralogy of Fallot
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Heart Defects, Congenital » Tetralogy of Fallot
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Congenital Abnormalities » Cardiovascular Abnormalities » Heart Defects, Congenital » Tetralogy of Fallot
Description
A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS. MeSH
Hierarchy View
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (1)
Phase 2 Indicated Drugs (1)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
